Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
Trial details
- Registry ID
- NCT04925024
- Drugs studied
- Lomecel-B medicinal signaling cells
TrialRedline tracks 2 clinical trials sponsored by Longeveron Inc.: 2 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.NCT04925024 | Lomecel-B medicinal signaling cells | Active not recruiting | 2026-06-30Estimated |
| Lomecel-B Effects on Alzheimer's DiseaseNCT05233774 | Allogeneic MSC | Completed | 2023-09-29Actual |
Names as written in the registry records.